Sarepta Therapeutics Inc banner

Sarepta Therapeutics Inc
NASDAQ:SRPT

Watchlist Manager
Sarepta Therapeutics Inc Logo
Sarepta Therapeutics Inc
NASDAQ:SRPT
Watchlist
Price: 18.31 USD Market Closed
Market Cap: $1.9B

Wall Street
Price Targets

SRPT Price Targets Summary
Sarepta Therapeutics Inc

Wall Street analysts forecast SRPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRPT is 30.93 USD with a low forecast of 5.05 USD and a high forecast of 194.25 USD.

Lowest
Price Target
5.05 USD
72% Downside
Average
Price Target
30.93 USD
69% Upside
Highest
Price Target
194.25 USD
961% Upside
Sarepta Therapeutics Inc Competitors:
Price Targets
RCKT
Rocket Pharmaceuticals Inc
143% Upside
FLEX
Flex Ltd
21% Upside
STG
Strip Tinning Holdings PLC
127% Upside

Revenue
Forecast

33% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
33% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Sarepta Therapeutics Inc's revenue is 33%. The projected CAGR for the next 4 years is -7%.

Operating Income
Forecast

N/A
Past Growth
-9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
-9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate of Sarepta Therapeutics Inc's operating income for the next 4 years is -9%.

Net Income
Forecast

N/A
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss
N/A
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss

The compound annual growth rate of Sarepta Therapeutics Inc's net income for the next 4 years is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRPT's stock price target?
Price Target
30.93 USD

According to Wall Street analysts, the average 1-year price target for SRPT is 30.93 USD with a low forecast of 5.05 USD and a high forecast of 194.25 USD.

What is Sarepta Therapeutics Inc's Revenue forecast?
Projected CAGR
-7%

For the last 13 years the compound annual growth rate for Sarepta Therapeutics Inc's revenue is 33%. The projected CAGR for the next 4 years is -7%.

What is Sarepta Therapeutics Inc's Operating Income forecast?
Projected CAGR
-9%

The compound annual growth rate of Sarepta Therapeutics Inc's operating income for the next 4 years is -9%.

What is Sarepta Therapeutics Inc's Net Income forecast?
Projected CAGR
7%

The compound annual growth rate of Sarepta Therapeutics Inc's net income for the next 4 years is 7%.

Back to Top